Ryan P. Bennett

OyaGen (United States)

Papers

1

Total Citations

20

H-Index

1

About

Ryan P. Bennett is a virologist whose research focuses on the molecular interplay between HIV and the host immune system, particularly the APOBEC3 family of antiviral proteins. His most impactful work, published in 2018, introduced a novel class of antiretroviral compounds that protect APOBEC3 from degradation by the HIV protein Vif. By preventing Vif from targeting APOBEC3 for destruction, these compounds restore the innate immune system’s ability to mutate and disable HIV’s genome, offering a fundamentally different therapeutic approach from traditional antiretrovirals. This study, which has garnered 20 citations, represents a significant step toward harnessing host defense mechanisms to combat viral infection. Bennett’s contributions are notable for bridging basic virology and drug development, highlighting how understanding virus-host conflicts can lead to innovative treatment strategies. His work is particularly relevant for researchers interested in innate immunity, HIV biology, and antiviral drug design, as it opens new avenues for therapies that work with, rather than against, the body’s natural defenses.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation
20 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: OyaGen (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago